ARTICLE | Clinical News
Ferumoxytol: Phase III expanded
August 15, 2005 7:00 AM UTC
As a result of FDA suggestions to change the primary efficacy analysis, AVM will enroll additional patients into its 2 Phase III ferumoxytol trials in stage 3 and stage 4 CKD patients. AVM did not dis...